In October the night before release of the 48 week results, Sarepta announced there would be a conference call the next morning at 8am to discuss the results. No hint about the nature of the results was given in that Oct 2 announcement. The rest is history. The 48 week results were announced in a press release on Oct. 3 at 7am, followed by the conference call at 8am. See the copy/paste of the October headlines from Yahoo Finance below.
If CG is going a similar route, we should have a major positive announcement tomorrow morning.
Tuesday, October 2, 2012
Sarepta Therapeutics Announces Conference Call and Webcast on Wednesday, October 3, 2012, to Discuss 48-Week Results From the Phase IIb DMD StudyMarketwired (Tue, Oct 2)
Wednesday, October 3, 2012
Sarepta Therapeutics Announces Eteplirsen Meets Primary Endpoint of Increased Novel Dystrophin and Achieves Significant Clinical Benefit on 6-Minute Walk Test After 48 Weeks of Treatment in Phase IIb Study in Duchenne Muscular DystrophyMarketwired (Wed, Oct 3)